During the past decade, Northwest Houston Cardiology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwest Houston Cardiology" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Northwest Houston Cardiology" are "Angina Pectoris" (2 trials), "ASCVD" (1 trials), "Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials) and "Hyperlipidemia" (1 trials). Many other conditions were trialed in "Northwest Houston Cardiology" in a lesser frequency.

Most popular intervention types in "Northwest Houston Cardiology" are "Drug" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bococizumab (PF-04950615; RN316)" (1 trials), "Sanqi+Bingpian" (1 trials), "T89" (1 trials) and "T89 Low dose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwest Houston Cardiology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Northwest Houston Cardiology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Northwest Houston Cardiology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northwest Houston Cardiology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".